Actively Recruiting
Efficacy of Nitrous Oxide in OCD: Pilot Study
Led by Stanford University · Updated on 2025-08-27
45
Participants Needed
1
Research Sites
336 weeks
Total Duration
On this page
Sponsors
S
Stanford University
Lead Sponsor
B
Brain & Behavior Research Foundation
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study investigates whether the commonly used and well-tolerated inhaled anesthetic nitrous oxide can rapidly improve symptoms of OCD.
CONDITIONS
Official Title
Efficacy of Nitrous Oxide in OCD: Pilot Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 to 65 years
- Primary diagnosis of obsessive-compulsive disorder (OCD)
- Sufficient severity of OCD symptoms
- Ability to tolerate a treatment-free period
- Capacity to provide informed consent
You will not qualify if you...
- Psychiatric or medical conditions that make participation unsafe
- Pregnant or nursing females
- Concurrent use of any medications that might increase the risk of participation (e.g. drug interactions)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Stanford University
Stanford, California, United States, 94304
Actively Recruiting
Research Team
P
Pavithra Mukunda, MS
CONTACT
S
Sindu Menon, MBBS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here